Literature DB >> 19336477

SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.

Simon T Cliffe1, Jamie M Kramer, Khalid Hussain, Joris H Robben, Eiko K de Jong, Arjan P de Brouwer, Esther Nibbeling, Erik-Jan Kamsteeg, Melanie Wong, Julie Prendiville, Chela James, Raja Padidela, Charlie Becknell, Hans van Bokhoven, Peter M T Deen, Raoul C M Hennekam, Robert Lindeman, Annette Schenck, Tony Roscioli, Michael F Buckley.   

Abstract

Pigmented hypertrichotic dermatosis with insulin-dependent diabetes (PHID) syndrome is a recently described autosomal recessive disorder associated with predominantly antibody negative, insulin-dependent diabetes mellitus. In order to identify the genetic basis of PHID and study its relationship with glucose metabolism, we performed homozygosity mapping in five unrelated families followed by candidate gene sequencing. Five loss-of-function mutations were identified in the SLC29A3 gene which encodes a member of a highly conserved protein family that transports nucleosides, nucleobases and nucleoside analogue drugs, hENT3. We show that PHID is allelic with a related syndrome without diabetes mellitus, H syndrome. The interaction of SLC29A3 with insulin signaling pathways was then studied using an established model in Drosophila melanogaster. Ubiquitous knockdown of the Drosophila ortholog of hENT3, dENT1 is lethal under stringent conditions; whereas milder knockdown induced scutellar bristle phenotypes similar to those previously reported in the knockdown of the Drosophila ortholog of the Islet gene. A cellular growth assay showed a reduction of cell size/number which could be rescued or enhanced by manipulation of the Drosophila insulin receptor and its downstream signaling effectors, dPI3K and dAkt. In summary, inactivating mutations in SLC29A3 cause a syndromic form of insulin-dependent diabetes in humans and in Drosophila profoundly affect cell size/number through interactions with the insulin signaling pathway. These data suggest that further investigation of the role of SLC29A3 in glucose metabolism is a priority for diabetes research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336477     DOI: 10.1093/hmg/ddp161

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Variability in the Manifestations and Evolution of Symptoms in a Patient with H Syndrome.

Authors:  Ruma Deshpande; Lavanya Parthasarathy; Ashwin Dalal; Vaman Khadilkar; Anuradha Khadilkar
Journal:  Indian J Pediatr       Date:  2015-05-14       Impact factor: 1.967

Review 2.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

3.  PfNT2, a permease of the equilibrative nucleoside transporter family in the endoplasmic reticulum of Plasmodium falciparum.

Authors:  Megan J Downie; Kamal El Bissati; April M Bobenchik; Laura Nic Lochlainn; Alexander Amerik; Rachel Zufferey; Kiaran Kirk; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

4.  Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.

Authors:  Nayoung Kang; Ah Hyun Jun; Yangzom Doma Bhutia; Natarajan Kannan; Jashvant D Unadkat; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

5.  A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.

Authors:  Anoop Mistry; David Parry; Bipin Matthews; Philip Laws; Mark Goodfield; Sinisa Savic
Journal:  J Clin Immunol       Date:  2016-05-23       Impact factor: 8.317

6.  Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

Authors:  Philippe M Campeau; James T Lu; Gautam Sule; Ming-Ming Jiang; Yangjin Bae; Simran Madan; Wolfgang Högler; Nicholas J Shaw; Steven Mumm; Richard A Gibbs; Michael P Whyte; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-08-08       Impact factor: 6.150

7.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

8.  Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.

Authors:  Neil V Morgan; Mark R Morris; Hakan Cangul; Diane Gleeson; Anna Straatman-Iwanowska; Nicholas Davies; Stephen Keenan; Shanaz Pasha; Fatimah Rahman; Dean Gentle; Maaike P G Vreeswijk; Peter Devilee; Margaret A Knowles; Serdar Ceylaner; Richard C Trembath; Carlos Dalence; Erol Kismet; Vedat Köseoğlu; Hans-Christoph Rossbach; Paul Gissen; David Tannahill; Eamonn R Maher
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

Review 9.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

Review 10.  [Autoinflammatory syndromes in childhood].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.